Studies On The Pathogenesis And Early Diagnosis Of Hepatocellular Carcinoma
Funder
National Health and Medical Research Council
Funding Amount
$100,082.00
Summary
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and worldwide is the third and fifth leading cause of cancer death in men and women respectively. Early diagnosis is vital to patient survival. Our research investigates new methods in the early diagnosis of HCC, including new protein markers of the cancer and non-invasive measurements of liver scarring. We also study the genetics of HCC and investigate new genes that could be targets for future therapies.